Evidence map›Paper›PMID 41392302›Full record

ArticleScientific reports2025

Developing a QSPR model for Alzheimer's drugs using topological indices and M-polynomial: A computational study.

Mohammad Hadi Akhbari, Fateme Movahedi, Mahsa Zameni, Mohammad Hassan Shahavi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad Hadi AkhbariDepartment of Mathematics, Es.C., Islamic Azad University, Estahban, Iran. hadi.akhbari@iau.ac.ir.
Fateme MovahediDepartment of Mathematics, Faculty of Sciences, Golestan University, Gorgan, Iran.
Mahsa ZameniDepartment of Nanotechnology, Faculty of Engineering Modern Technologies, Amol University of Special Modern Technologies, Amol, Iran.
Mohammad Hassan ShahaviDepartment of Nanotechnology, Faculty of Engineering Modern Technologies, Amol University of Special Modern Technologies, Amol, Iran. m.shahavi@ausmt.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topological indices, which are numerical descriptors that encode molecular structure, are widely used in computational drug discovery due to their efficiency and interpretability. In this study, we developed a robust quantitative structure-property relationship (QSPR) framework to predict the core physicochemical properties of nine clinically relevant Alzheimer's disease drugs, including Donepezil, Galantamine, and Memantine.​ We employed a streamlined computational approach, using MATLAB and the M-polynomial method, to efficiently calculate a series of degree-based topological indices. Through comprehensive regression analyses, we identified strong correlations between degree-based topological indices and key physicochemical properties, including boiling point and molar refractivity. While linear models provided a reasonable baseline, nonlinear models, particularly cubic and power equations, delivered significantly improved predictive accuracy. The analysis highlighted the critical interplay between the choice of the index and the regression model. For instance, the cubic model was frequently the most effective for predicting properties such as boiling point and flash point, while the power model performed best for molar refractivity and polarizability. Notably, the redefined first Zagreb index and the modified first Zagreb index exhibited exceptional predictive capacity, reflecting their sensitivity to structural features that govern physicochemical behavior. The strong performance of these QSPR models underscores their potential to accelerate the rational design of Alzheimer's therapeutics. By enabling rapid, cost-effective, and reliable property prediction prior to synthesis, this framework offers a valuable tool for future drug development efforts.

Indexed as

Alzheimer DiseaseDrug DiscoveryQuantitative Structure-Activity RelationshipDonepezilGalantamineHumansMemantineDonepezilGalantamineMemantineM-polynomialPhysicochemical propertyQSPR modelRegression modelTopological index

Identifiers

PMID41392302
PMCPMC12804841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.